Reaching Others University at Buffalo - The State University of New York
Skip to Content
UB Reporter

Research News

Sharing
10/16/14

Four research projects have received seed funding under RENEW, UB’s new interdisciplinary environmental research initiative.

Reducing hazmat risk
10/20/14

UB researcher Changhyun Kwon has received a NSF CAREER Award to build a routing simulator that would reduce catastrophic hazardous materials accidents.

Architect Barbie, three years later
10/16/14

Architect Barbie co-creaters Despina Stratigakos and Kelly Hayes McAlonie are traveling to Washington, D.C., to talk about how the gender debate in the profession has changed.

Continuing HIV drug development
10/16/14

The School of Pharmacy and Pharmaceutical Sciences has received three grants totaling $3.85 million from the National Institutes of Health for the Translational Pharmacology Research Core and its HIV Clinical Pharmacology Research Program.

RENEW awards seed funding
10/16/14

Four research projects have received seed funding under RENEW, UB’s new interdisciplinary environmental research initiative.

Transforming patient care
10/16/14

In response to new 'game-changing' hepatitis C treatments, UB has launched a clinical care center to advance research, clinical management and education on liver disease.

Food (policy) back on the table
10/16/14

A new UB study outlines seven factors that led one of America’s poorest cities to embrace farming, urban chickens and more

Extending battery life
10/13/14

Three UB research groups have received a combined $1.3 million in federal grants to improve smartphone energy management.

Rights acquired to spider-venom drug
10/9/14

A clinical-stage biopharmaceutical company has acquired the rights to a drug that UB scientists have begun developing for Duchenne muscular dystrophy, a common, fatal genetic disease affecting young boys.

Friedman receives another honor
10/9/14

UB faculty member Kathryn Bryk Friedman has been appointed to a prominent SUNY fellowship program designed to foster research collaborations across the state campus system.

Reducing precancerous polyps
10/9/14

An oral biologic medication has successfully treated chronic, precancerous inflammation in the intestine, according to results of an animal study authored by a UB MD/PhD student.